Ajax-Loading

Elevance Health Inc - Price To Sales Ratio

Elevance Health Inc's Fiscal Year is From January To December.

The item "Price-To-Sales-Ratio" stands at 0.3562 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of Elevance Health Inc's third quarter, the item "Price To Sales Ratio" stands at 0.3562. This represents a decrease of -17.43 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -45.51 percent compared to the value the year prior.
The 1 year change in percent is -45.51.
The 3 year change in percent is -44.10.

The Serie's long term average value is 0.588. It's latest available value, on 09/30/2025, is 39.46 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -52.73%.

Price To Sales Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoUnitedHealth Group Incorporated - Price To Sales Ratio299,751,047,168.00
LogoHumana Inc - Price To Sales Ratio31,012,411,392.00
LogoCentene Corp - Price To Sales Ratio18,844,801,024.00
LogoMolina Healthcare Inc - Price To Sales Ratio8,230,812,160.00
LogoHealthEquity Inc - Price To Sales Ratio8,172,785,664.00